Latest Healthcare in India Stories
SINGAPORE, May 4, 2011 /PRNewswire/ -- S*BIO Pte Ltd today announced the restructuring of its collaboration and option agreement with Onyx Pharmaceuticals, which was entered into in January 2009.
NEW YORK, April 29, 2011 /PRNewswire/ -- Keryx Biopharmaceuticals, Inc.
POINT RICHMOND, Calif., April 7, 2011 /PRNewswire/ -- Transcept Pharmaceuticals, Inc.
ALISO VIEJO, Calif., April 5, 2011 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that company management will present an overview of the company at the Future Leaders in the Biotech Industry Conference in New York City.
CALGARY, March 31 /PRNewswire-FirstCall/ - Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC) (NASDAQ: ONCY), will present a corporate overview of the Company at the 10(th) Annual Needham Healthcare Conference on Tuesday, April 5(th), 2011 at 10:00 a.m. ET.
In this week's PLoS Medicine, K. Srinath Reddy from the Public Health Foundation of India discusses new research published last week by Malavika Subramanyam, S V Subramanian, and colleagues that found no link between economic growth and child undernutrition rates in India, concluding that direct investments in appropriate health interventions may be necessary to improve child health in India.
LOS ANGELES, March 7, 2011 /PRNewswire/ -- Genesis Biopharma, Inc. (OTC Bulletin Board: GNBP), a biotechnology company developing targeted cancer therapies, today announced it has named Marvin S. Hausman M.D. as Chief Science Officer. Dr.
CALGARY, March 3 /PRNewswire-FirstCall/ - Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC) (NASDAQ: ONCY), will present a corporate overview of the Company at the 31(st) Annual Cowen and Company Healthcare Conference on Tuesday, March 8(th), 2011 at 8:45 a.m. ET.
SAN DIEGO, March 2, 2011 /PRNewswire/ -- Cadence Pharmaceuticals, Inc.
HONG KONG, March 1 /PRNewswire/ - Today, www.WorldStreetFundamentals.com released its industry report highlighting Keryx Biopharmaceuticals (NASDAQ: KERX) and Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ).
- A transitional zone between two communities containing the characteristic species of each.